Benzinga | Sep 27, 2021 04:10PM EDT

Aytu BioScience Q4 Sales $23.50M Beat $20.90M Estimate

Aytu BioScience (NASDAQ:AYTU) reported quarterly sales of $23.50 million which beat the analyst consensus estimate of $20.90 million by 12.44 percent. This is a 58.13 percent increase over sales of $14.86 million the same period last year.